Literature DB >> 9454903

The role of protein kinase C in G1 and G2/M phases of the cell cycle (review).

D D Fishman1, S Segal, E Livneh.   

Abstract

The protein serine/threonine kinases--members of protein kinase C (PKC) family--are important components of the major signaling pathways regulating cell proliferation and differentiation. Recent studies implicate PKC in cell cycle control at two sites--during G1 to S progression and at G2 to M transition. Activation of PKC during G1 progression modulates the activity of the specific cyclin-dependent kinases (CDKs), which phosphorylate the retinoblastoma susceptibility gene product (RB). Phosphorylation of RB is a pivotal event in cell cycle progression leading to G1/S transition. PKC mediated enhancement or inhibition of CDK's activity and the RB phosphorylation state appear to be dependent on the precise timing of PKC activation during G1 and on the particular cell type. At G2/M transition, recent evidence suggests that PKC is involved in the regulation of CDC2 activity, although it is mostly implicated as a regulator of lamin B phosphorylation and the nuclear lamina disassembly.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454903     DOI: 10.3892/ijo.12.1.181

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  13 in total

1.  Translational control of protein kinase Ceta by two upstream open reading frames.

Authors:  Hadas Raveh-Amit; Adva Maissel; Jonathan Poller; Liraz Marom; Orna Elroy-Stein; Michal Shapira; Etta Livneh
Journal:  Mol Cell Biol       Date:  2009-09-21       Impact factor: 4.272

2.  Discoidin domain receptor 2 mediates tumor cell cycle arrest induced by fibrillar collagen.

Authors:  Steven J Wall; Erica Werner; Zena Werb; Yves A DeClerck
Journal:  J Biol Chem       Date:  2005-09-26       Impact factor: 5.157

Review 3.  Protein kinase C and cancer: what we know and what we do not.

Authors:  R Garg; L G Benedetti; M B Abera; H Wang; M Abba; M G Kazanietz
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

4.  Cellular activation triggered by the autosomal dominant polycystic kidney disease gene product PKD2.

Authors:  T Arnould; L Sellin; T Benzing; L Tsiokas; H T Cohen; E Kim; G Walz
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

5.  Involvement of p21(Waf1/Cip1) in protein kinase C alpha-induced cell cycle progression.

Authors:  A Besson; V W Yong
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

6.  Protein kinase C mediates phosphorylation of the regulatory light chain of myosin-II during mitosis.

Authors:  O Varlamova; A Spektor; A R Bresnick
Journal:  J Muscle Res Cell Motil       Date:  2001       Impact factor: 2.698

7.  Analysis of protein kinase C delta (PKC delta) expression in endometrial tumors.

Authors:  Elaine M Reno; James M Haughian; Irina K Dimitrova; Twila A Jackson; Kenneth R Shroyer; Andrew P Bradford
Journal:  Hum Pathol       Date:  2007-10-24       Impact factor: 3.466

Review 8.  Anti-oxidants from green tea and pomegranate for chemoprevention of prostate cancer.

Authors:  Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Mol Biotechnol       Date:  2007-09       Impact factor: 2.695

9.  Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma.

Authors:  Anthony P Lam; Joseph A Sparano; Vincent Vinciguerra; Allyson J Ocean; Paul Christos; Howard Hochster; Fernando Camacho; Sanjay Goel; Sridhar Mani; Andreas Kaubisch
Journal:  Am J Clin Oncol       Date:  2010-04       Impact factor: 2.339

10.  PKC alpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1.

Authors:  Qianying Gao; Juan Tan; Ping Ma; Jian Ge; Yaqin Liu; Xuerong Sun; Lian Zhou
Journal:  Mol Vis       Date:  2009-12-10       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.